Skip to main content
. 2022 May 10;12(5):772. doi: 10.3390/jpm12050772

Figure 2.

Figure 2

EV-associated biomarkers and prognostic factors with potential impact on the immune system of RCC patients, found in urine and blood. Created with BioRender. Abbreviations: AAMP—Angio-associated migratory cell protein; ALOX5—Arachidonate 5-lipoxygenase; CA-9—Cancer antigen 9; CAPNS1—Calpain small subunit 1; CEBPA—CCAAT/Enhancer binding protein alpha; CYB—Cytochrome B; EV—extracellular vesicle; GGT—Gamma-glutamyl transferase; GSTA1—Glutathione S-transferase A1; hsa-miR—human microRNA; HV1—Hirudin variant 1; miR—microRNA; MYL12B—Myosin light chain 12B; NME2—Nucleoside diphosphate kinase B; PCBD1—Pterin-4-alpha-carbinolamine dehydratase 1; PTRF—Polymerase and transcript release factor; RCC—renal cell carcinoma; RBL2—Retinoblastoma-like protein 2; TIMP-1—Tissue inhibitor of metalloproteinase 1; TLK2—Tousled-like kinase 2; VAMP8—Vesicle associated membrane protein 8; VEGF—Vascular endothelial growth factor-A.